Supernus Pharmaceuticals reported $56.12M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.


Ordinary Share Capital Change Date
Abbott USD 25.12B 28M Mar/2025
ANI Pharmaceuticals USD 2K 0 Mar/2025
Aurora Cannabis CAD 56.25M 6.92B Jun/2025
Bristol-Myers Squibb USD 2.04B 1.74B Jun/2025
Canopy Growth CAD 205.15M 8.47B Jun/2025
Corcept Therapeutics USD 105.29M 105.15M Jun/2025
Eisai JPY 282.12M 44.7B Jun/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Novo Nordisk 4.44B 3.99B Jun/2025
Pacira USD 44.9M 44.85M Jun/2025
Perrigo USD 137.6M 6.56B Jun/2025
Pfizer USD 5.68B 5.2B Jun/2025
Supernus Pharmaceuticals USD 56.12M 130K Jun/2025
United Therapeutics USD 45.22M 44.42M Jun/2025
Xeris Pharmaceuticals USD 161.22M 161.21M Jun/2025